Synthetic Archaeosome Vaccines Containing Triglycosylarchaeols Can Provide Additive and Long-Lasting Immune Responses That Are Enhanced by Archaetidylserine
Figure 8
Maturation of dendritic cells (DCs) upon treatment with archaeosomes as measured by decrease of FITC-dextran uptake. Bone marrow DCs treated with archaeosomes in vitro were compared for their ability to take up FITC-dextran. The results depict the mean MFI (37–4°C). Data represent means ± SD of triplicate cultures as indicated.
